Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 841 to 855 of 7709 results

  1. Hybrid closed loop systems for managing blood glucose levels in type 1 diabetes (TA943)

    Evidence-based recommendations on hybrid closed loop systems for managing blood glucose levels in type 1 diabetes.

  2. Treosulfan with fludarabine before allogeneic stem cell transplant for people aged 1 month to 17 years with non-malignant diseases (terminated appraisal) (TA945)

    NICE is unable to make a recommendation on treosulfan (Trecondi) with fludarabine before allogeneic stem cell transplant for babies, children and young people aged 1 month to 17 years with non-malignant diseases. This is because Medac Pharma did not provide an evidence submission. We will review this decision if the company decides to make a submission.

    Sections for TA945

  3. Loncastuximab tesirine for treating relapsed or refractory diffuse large B-cell lymphoma and high-grade B-cell lymphoma after 2 or more systemic treatments (TA947)

    Evidence-based recommendations on loncastuximab tesirine (Zynlonta) for treating relapsed or refractory diffuse large B-cell lymphoma and high-grade B-cell lymphoma in adults after 2 or more systemic treatments.

  4. Ivosidenib for treating advanced cholangiocarcinoma with an IDH1 R132 mutation after 1 or more systemic treatments (TA948)

    Evidence-based recommendations on ivosidenib (Tibsovo) for treating locally advanced or metastatic cholangiocarcinoma with an IDH1 R132 mutation in adults after 1 or more systemic treatments.

  5. Belumosudil for treating chronic graft-versus-host disease after 2 or more systemic treatments in people 12 years and over (TA949)

    Evidence-based recommendations on belumosudil (Rezurock) for chronic graft-versus-host disease in people 12 years and over after 2 or more systemic treatments.

  6. Olaparib with abiraterone for untreated hormone-relapsed metastatic prostate cancer (TA951)

    Evidence-based recommendations on olaparib (Lynparza) with abiraterone for untreated hormone-relapsed metastatic prostate cancer in adults.

  7. Tafamidis for treating transthyretin amyloidosis with cardiomyopathy (TA984)

    Evidence-based recommendations on tafamidis (Vyndaqel) for treating transthyretin amyloidosis with cardiomyopathy in adults.

  8. Arranging services for people with a learning disability and behaviour that challenges

    A quick guide for commissioners People with a learning disability (or autism and a learning disability) and behaviour that challenges should have the

  9. Better home care for older people

    A quick and easy-to-read guide to the standard of care you should expect from a home care provider.

  10. Creating a safeguarding culture

    A quick guide to creating a safeguarding culture

  11. Developing a positive working culture for supporting disabled children and young people with severe complex needs

    NICE'S quick guide to developing a positive working culture for supporting disabled children and young people with severe complex needs

  12. Effective record keeping and ordering of medicines

    A quick guide for home care managers providing medicines support

  13. Evidence for strengths and asset-based outcomes

    A quick guide for social workers Strengths and asset-based approaches in social care focus on what individuals and communities have and how they can...

  14. Giving medicines covertly

    A quick guide for care home managers and home care managers providing medicines support

  15. Helping to prevent infection

    Help for care home managers and staff to prevent infection